The prescription of a higher number of phosphate binder pills is associated with lower medication adherence and worse serum phosphorus control
Kyoko Ito, Tetsuya Ogawa(Nihon University), Takaaki Tsutsui(Hidaka Hospital), Tomoi Nohara(Hidaka Hospital), Nobuo Nagano(Kirin (Japan)), Kosaku Nitta(Tokyo Women's Medical University), Tetsuo Ando, Hideki Ishida(Hidaka Hospital), Ayaka Tagahara(Hidaka Hospital), T Takahashi(Hidaka Hospital), Noriko Tamei(Hidaka Hospital), Atsushi Nohara(Kanazawa University), Hiroshi Sakura(Tokyo Women's Medical University Adachi Medical Center), Mari Okajima(Hidaka Hospital), Ayako Hoshi(Hidaka Hospital), Miho Tsukada(Hidaka Hospital)
Cited by 4
Related Papers
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
|Therapeutic Apheresis and Dialysis|2015|425
Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
|Journal of Atherosclerosis and Thrombosis|2018|226
Guidelines for the Management of Familial Hypercholesterolemia
|Journal of Atherosclerosis and Thrombosis|2012|177
Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality
|Renal Replacement Therapy|2020|170